Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.
about
Multiple Sclerosis and Obesity: Possible Roles of AdipokinesAcute suppression of circulating sCD40L during hyperglycemia and euglycemic-hyperinsulinemia in healthy young males.The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people.Obesity related alterations in plasma cytokines and metabolic hormones in chimpanzees.Emerging markers of atherosclerosis before and after bariatric surgerySoluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac CatheterizationCure of type 2 diabetes by metabolic surgery? A critical analysis of the evidence in 2010.Obesity and inflammation: lessons from bariatric surgery.Assessment of serum levels of soluble CD40L in Egyptian children and adolescents with type 1 diabetes mellitus: Relationship to microalbuminuria and glycemic control.Decreased Levels of Circulating Cancer-Associated Protein Biomarkers Following Bariatric Surgery.Platelet activation in obesity and metabolic syndrome.The impact of bariatric surgery on inflammation: quenching the fire of obesity?Duodenal-Jejunal bypass improves glucose homeostasis in association with decreased proinflammatory response and activation of JNK in the liver and adipose tissue in a T2DM rat model.Heterozygosity for the rs696217 SNP in the Preproghrelin Gene Predicts Weight Loss After Bariatric Surgery in Severely Obese Individuals.
P2860
Q28078518-05CC7723-1623-4522-93E7-B74748EA21CFQ33768652-AD6C0689-EE9F-4114-8906-F142BE8448FFQ34020389-8EE18442-ACEE-4A1C-B9E7-C3A43FFB8C7FQ34278709-BD1EDB0C-0AD2-4DC8-83AD-C104D5E99E0BQ35138237-D4B03CD4-5574-4282-8BB3-05BF6C698BFAQ35735264-8DC89DAE-4C96-433C-A9D1-B6252B348851Q36790184-94F3A268-8E11-4C72-B3EB-0AAE2312EEE8Q37313752-C309047C-D93E-4E49-8A11-3A2CE6E8B2A1Q37413941-1012BCF3-2DC5-428B-B7A7-CC46DBB90859Q37639541-BBFA6465-8D19-4854-B494-FC106E20A663Q37932076-88FA7935-8FA7-4061-8069-DF5CD33964F0Q38838093-4D6F78F3-507C-405D-9AA9-C2CCDBDF6AE9Q46116943-8CB90150-8C07-4A02-84F0-9C0CD904C4F5Q47270963-6D845F7E-ED45-4265-B5CD-83D36E35B11D
P2860
Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Soluble CD40L in patients with ...... ction after bariatric surgery.
@en
Soluble CD40L in patients with ...... ction after bariatric surgery.
@nl
type
label
Soluble CD40L in patients with ...... ction after bariatric surgery.
@en
Soluble CD40L in patients with ...... ction after bariatric surgery.
@nl
prefLabel
Soluble CD40L in patients with ...... ction after bariatric surgery.
@en
Soluble CD40L in patients with ...... ction after bariatric surgery.
@nl
P2093
P2860
P1476
Soluble CD40L in patients with ...... ction after bariatric surgery.
@en
P2093
Koppensteiner R
Kriwanek S
Krzyzanowska K
Schernthaner G
Schernthaner GH
P2860
P304
P356
10.1111/J.1365-2362.2006.01649.X
P577
2006-06-01T00:00:00Z